Clariane Overview
- Year Founded
-
2003
- Status
-
Public
- Employees
-
70,000
- Stock Symbol
-
CLARI
- Investments
-
51
- Share Price
-
$3.76
- (As of Friday Closing)
Clariane General Information
Description
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
Contact Information
Website
www.clariane.comCorporate Office
- 21 - 25 Rue Balzac
- 75008 Paris
- France
Corporate Office
- 21 - 25 Rue Balzac
- 75008 Paris
- France
Clariane Timeline
Clariane Stock Performance
As of 13-Nov-2026, Clariane’s stock price is $3.76. Its current market cap is $1.34B with 357M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.76 | $3.85 | $3.35 - $5.22 | $1.34B | 357M | 395K | $0.04 |
Clariane Financials Summary
As of 30-Jun-2026, Clariane has a trailing 12-month revenue of $6.25B.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 9,981,997 | 10,794,080 | 9,327,926 | 9,516,705 |
| Revenue | 6,245,345 | 5,990,051 | 5,715,383 | 5,405,598 |
| EBITDA | 1,216,302 | 1,152,957 | 1,064,812 | 1,030,177 |
| Net Income | 14,659 | 1,799 | (59,649) | (113,883) |
| Total Assets | 16,397,373 | 16,217,810 | 14,839,514 | 16,780,977 |
| Total Debt | 9,530,107 | 9,170,079 | 8,305,226 | 9,456,621 |
Clariane Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Clariane Comparisons
Industry
Financing
Details
Clariane Competitors (2)
One of Clariane’s 2 competitors is Barchester Healthcare, a Private Equity-Backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Barchester Healthcare | Private Equity-Backed | London, United Kingdom | ||||
| Emeis | Corporate Backed or Acquired | Puteaux, France |
Clariane Signals
Clariane Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Clariane Investments & Acquisitions (51)
Clariane’s most recent deal was a Corporate Asset Purchase with Clariane (Neurodevelopment Center in Madrid, Spain). The deal was made on 19-Mar-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Clariane (Neurodevelopment Center in Madrid, Spain) | 19-Mar-2026 | Corporate Asset Purchase | Buildings and Property | ||
| Centro de Rehabilitación Dionisia Plaza | 18-Mar-2026 | Merger/Acquisition | Hospitals/Inpatient Services | ||
| Grupo 5 | 01-Jan-2023 | Merger/Acquisition | Elder and Disabled Care | ||
| Kaspard | 02-Aug-2021 | Early Stage VC | Monitoring Equipment | ||
| Centre de Psychothérapie d'Osny | 01-Jul-2021 | Merger/Acquisition | Hospitals/Inpatient Services |
Clariane ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
22.04 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Facilities
Subindustry
of 117
Rank
Percentile
Clariane Exits (10)
Clariane’s most recent exit was on 19-Apr-2021 from Intensivpflegedienst Lebenswert. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Intensivpflegedienst Lebenswert | 19-Apr-2021 | Completed |
|
||
| Berkley Care Group | 17-Mar-2021 | Completed |
|
||
| VivaSon | 21-Jan-2021 | Completed |
|
||
| Clariane (Six Care Properties in Netherlands) | 10-Dec-2020 | Completed |
|
||
| Les Essentielles | 01-Jun-2020 | Merger/Acquisition | Completed |
Clariane Affiliates
Subsidiaries (131)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Korian Etoile Immobilier 3 | Paris, France | 2022 | |
| Sopraviva | Eguzon-Chantome, France | 2022 | |
| Clariane & Partenaires Immobilier 2 | Paris, France | 2020 | |
| Betreuung Und Pflege Zuhause Hunderdorf | Munich, Germany | 2019 | |
| Sas Korian Asset & Property Management | Paris, France | 2019 |
Clariane FAQs
-
When was Clariane founded?
Clariane was founded in 2003.
-
Where is Clariane headquartered?
Clariane is headquartered in Paris, France.
-
What is the size of Clariane?
Clariane has 70,000 total employees.
-
What industry is Clariane in?
Clariane’s primary industry is Elder and Disabled Care.
-
Is Clariane a private or public company?
Clariane is a Public company.
-
What is Clariane’s stock symbol?
The ticker symbol for Clariane is CLARI.
-
What is the current stock price of Clariane?
As of 13-Nov-2026 the stock price of Clariane is $3.76.
-
What is the current market cap of Clariane?
The current market capitalization of Clariane is $1.34B.
-
What is Clariane’s current revenue?
The trailing twelve month revenue for Clariane is $6.25B.
-
Who are Clariane’s competitors?
Barchester Healthcare and Emeis are competitors of Clariane.
-
What is Clariane’s annual earnings per share (EPS)?
Clariane’s EPS for 12 months was $0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process